Prospera Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.3M Sell
46,944
-896
-2% -$915K 0.82% 18
2026
Q1
$44M Sell
47,840
-6,250
-12% -$6.34M 0.71% 23
2025
Q4
$58.1M Buy
54,090
+980
+2% +$937K 0.95% 15
2025
Q3
$40.5M Buy
53,110
+8,147
+18% +$6.06M 0.69% 23
2025
Q2
$35.1M Buy
44,963
+17,702
+65% +$13.8M 0.65% 26
2025
Q1
$22.5M Buy
27,261
+1,884
+7% +$1.57M 0.52% 37
2024
Q4
$19.6M Buy
25,377
+748
+3% +$619K 0.46% 47
2024
Q3
$21.8M Buy
24,629
+1,642
+7% +$1.48M 0.56% 36
2024
Q2
$20.8M Buy
22,987
+3,100
+16% +$2.48M 0.58% 30
2024
Q1
$15.5M Buy
19,887
+7,382
+59% +$5.25M 0.46% 40
2023
Q4
$7.29M Buy
12,505
+706
+6% +$412K 0.24% 93
2023
Q3
$6.34M Buy
11,799
+712
+6% +$367K 0.25% 93
2023
Q2
$5.2M Buy
11,087
+652
+6% +$273K 0.2% 123
2023
Q1
$3.59M Buy
10,435
+1,436
+16% +$484K 0.15% 170
2022
Q4
$3.29M Sell
8,999
-4,076
-31% -$1.45M 0.16% 144
2022
Q3
$4.23M Buy
13,075
+1,575
+14% +$499K 0.22% 109
2022
Q2
$3.73M Buy
11,500
+2,669
+30% +$801K 0.19% 122
2022
Q1
$2.53M Buy
8,831
+72
+0.8% +$18.5K 0.11% 233
2021
Q4
$2.42M Buy
8,759
+635
+8% +$161K 0.1% 228
2021
Q3
$1.88M Buy
8,124
+1,573
+24% +$388K 0.09% 247
2021
Q2
$1.5M Buy
6,551
+43
+0.7% +$8.64K 0.08% 298
2021
Q1
$1.22M Sell
6,508
-736
-10% -$144K 0.07% 301
2020
Q4
$1.22M Buy
7,244
+2,860
+65% +$427K 0.08% 253
2020
Q3
$649K Sell
4,384
-23,136
-84% -$3.58M 0.25% 73
2020
Q2
$4.52M Sell
27,520
-7,472
-21% -$1.15M 0.4% 46
2020
Q1
$4.85M Buy
34,992
+29,671
+558% +$4.08M 0.52% 31
2019
Q4
$699K Buy
5,321
+150
+3% +$17.4K 0.05% 313
2019
Q3
$578K Sell
5,171
-41
-0.8% -$4.57K 0.06% 274
2019
Q2
$583K Sell
5,212
-22
-0.4% -$2.59K 0.07% 259
2019
Q1
$667K Buy
5,234
+1,503
+40% +$183K 0.22% 129
2018
Q4
$430K Sell
3,731
-1,788
-32% -$200K 0.09% 223
2018
Q3
$569K Sell
5,519
-215
-4% -$21.5K 0.11% 193
2018
Q2
$493K Sell
5,734
-535
-9% -$43.9K 0.07% 235
2018
Q1
$490K Buy
6,269
+1,726
+38% +$139K 0.07% 242
2017
Q4
$387K Sell
4,543
-4,986
-52% -$424K 0.06% 264
2017
Q3
$826K Sell
9,529
-150
-2% -$12.3K 0.13% 157
2017
Q2
$791K Sell
9,679
-4,579
-32% -$374K 0.13% 158
2017
Q1
$1.21M Buy
14,258
+895
+7% +$71.7K 0.22% 93
2016
Q4
$993K Buy
13,363
+1,152
+9% +$85.8K 0.19% 102
2016
Q3
$980K Buy
12,211
+3,897
+47% +$312K 0.2% 95
2016
Q2
$655K Buy
8,314
+1,062
+15% +$80K 0.14% 133
2016
Q1
$530K Sell
7,252
-14,145
-66% -$1.07M 0.12% 138
2015
Q4
$1.8M Buy
21,397
+15,301
+251% +$1.27M 0.4% 40
2015
Q3
$460K Sell
6,096
-663
-10% -$56K 0.12% 126
2015
Q2
$514K Buy
6,759
+456
+7% +$34.7K 0.12% 130
2015
Q1
$414K Sell
6,303
-1,365
-18% -$97.2K 0.09% 161
2014
Q4
$529K Buy
7,668
+2
+0% +$135 0.13% 125
2014
Q3
$458K Sell
7,666
-680
-8% -$43.1K 0.12% 136
2014
Q2
$519K Sell
8,346
-378
-4% -$22.6K 0.14% 120
2014
Q1
$478K Buy
8,724
+951
+12% +$53.1K 0.15% 104
2013
Q4
$396K Sell
7,773
-652
-8% -$32.6K 0.13% 126
2013
Q3
$427K Buy
8,425
+201
+2% +$10.5K 0.16% 120
2013
Q2
$413K Buy
+8,224
New +$447K 0.19% 118

Other funds holding LLY

Prospera Financial Services's LLY Position: Q2 2026 in Review

Prospera Financial Services reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $915K and leaving 46,944 shares worth $56.3M. The position accounts for 0.82% of the portfolio, ranked #18.

Prospera Financial Services first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.1M in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Prospera Financial Services held 46,944 shares of Eli Lilly worth $56.3M as of Q2 2026.
  • Prospera Financial Services sold 896 Eli Lilly shares in Q2 2026, an estimated $915K.
  • Eli Lilly made up 0.82% of Prospera Financial Services's portfolio in Q2 2026, its #18 holding.
  • Prospera Financial Services first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Prospera Financial Services's Eli Lilly position peaked at $58.1M in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.